Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis B: Symptoms and treatment
Hepatitis B (Hep B, HBV) What is Hepatitis? Hepatitis is inflammation of the liver. One of the primary causes of hepatitis is a viral infection. There are several viruses that may cause acute hepatitis (temporary liver inflammation), or chronic hepatitis

The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals
Rein DB et al. - According to estimates, vaccinating with combination vaccine resulted in a cost of $120,000 per quality adjusted life year gained (2.79 times the 2005 United States Gross Domestic Product per capita), a ratio that is less favorable than

Hepatitis
What do drugs, alcohol, premarital and unprotected sex, tattoos and body piercings have in common? ?The In Thing? WRONG They're all things your parents probably lecture you about avoiding, but there's another connection as well - they can all lead to

UPDATES AND COMMENTARY RSS Feed

The Hepatitis Vaccine That Does Double Duty
People who have Hepatitis C and have not been vaccinated against Hepatitis A or Hepatitis B could benefit from the combined hepatitis vaccine....

Medical Spas May Pose Hepatitis Risk
Since medical spas are offering more treatments involving the use of needles, the potential for Hepatitis C transmission is rising. Learn about some of the spa treatment techniques that pose hepatitis transmission dangers, as well as five ways to increase...

Hepatitis B Treatment May Reduce Pancreatic Cancer Risk
While several theories are attempting to explain the connection, scientists are unsure why those with Hepatitis B appear to have a 2 1/2 fold increase in risk for developing pancreatic cancer. Once the link is understood, Hepatitis B treatment may...

Semin Gastrointest Dis 1998 Jul;9(3):86-109

Recurrent disease after liver transplantation.

Davern TJ, Lake JR

Department of Medicine, University of California, San Francisco 94143-0538, USA.

Most liver diseases for which liver transplantation is performed recur after liver transplantation. The clinical impact of recurrence varies. For autoimmune liver diseases, such as primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis, clinically significant recurrence appears to be relatively rare. Whether these diseases recur in any meaningful way after liver transplantation is still controversial. For the chronic viral diseases, hepatitis B and C, the issue is not whether they recur--they clearly do--but whether the recurrence affects prognosis and how best to manage recurrent disease. For hepatitis B virus (HBV), reinfection can lead to accelerated liver injury, graft loss, and dramatically worse patient and graft survival rates, whereas the prognosis of recurrent hepatitis C virus (HCV), at least in the short-term, appears to be more benign. Major advances have been made in preventing liver allograft reinfection with HBV. Before these advances, chronic hepatitis B was considered a relative contraindication to liver transplantation because the allografts almost always became reinfected. With the current strategies for preventing HBV reinfection, however, the graft and patient survival rates after transplantation for chronic hepatitis B approach those for nonviral diseases. The development of resistance to antiviral therapy is likely to represent the major problem in the future and mandate the use of combination therapy. There is currently no effective therapy available for recurrent hepatitis C. Until such therapy is developed, recurrent hepatitis C remains the most challenging problem facing liver transplant physicians and surgeons.

PMID: 9700841, UI: 98366199

table Of Contents

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 13 Oct 2008